跳至主要内容
临床试验/CTRI/2024/04/066009
CTRI/2024/04/066009尚未招募不适用

STUDY OF CLINICAL OUTCOME AND RECURRENCE PATTERN OF TRIPLE NEGATIVE BREAST CANCER IN NORTH INDIA.

Nill1 个研究点 分布在 1 个国家目标入组 83 人开始时间: 2024年4月29日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
83
试验地点
1
主要终点
1. clinical outcome of TNBC patient.

研究概览

简要总结

Breast cancer is the most common female cancer world�’wide.

Molecular studies of breast carcinoma have classified the tumour based on the immunohistochemical staining into 4 subtypes, such as Luminal A, Luminal B, HER2/neu Positive and Triple Negative Breast Carcinoma (TNBC)

Triple-negative breast cancer (TNBC), characterized by the lack of expression of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2, is typically associated with a poor prognosis.

TNBCs are reported to have an aggressive behaviour and wide metastasis, leading to selective treatment outcomes.

The aim was to know clinical outcome and recurrence pattern of triple negative breast cancer in patients from north india.

Objectives of study are to know the clinical features of TNBC patient, to access clinical response of TNBC patient after initiate of treatment, to know recurrence pattern of TNBC and to identify factors associated with early recurrence in TNBC patient.

The implication of study is that we can analyze the clinicopathological features of Triple Negative breast cancer and to compare it with reports from other regions of the world. It also provides prognostic significance of TN breast cancer. We can compare outcome and survival patterns of TNBC patient treated with various chemotherapy regimens and surgery.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
Female

入选标准

  • Female patient Age more than 18 years Age less than 70 years Biopsy and immunohistochemistry and IHC proved TNBC at MPMMCC Varanasi Patient operated at MPMMCC Varanasi.

排除标准

  • Male patient Age less than 18 years Age more than 70 years Other pathological subtypes of breast cancer Non operated cases.

结局指标

主要结局

1. clinical outcome of TNBC patient.

时间窗: 1 year

2.access clinical response of TNBC patient after initiate of treatment

时间窗: 1 year

3.identify factors associated with early recurrence in TNBC patient.

时间窗: 1 year

次要结局

  • To study the cliniopathological features of TNBC patient.(12 months)

研究者

发起方
Nill
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Dr Mayank Tripathi

Consultant

研究点 (1)

Loading locations...

相似试验